Artificial Intelligence (AI) is transforming the world of hematology and hematopathology. In a recent update on AI-based hematopathology, Scopio Labs has announced the launch of the Full-Field Bone Marrow AspirateTM (FF-BMA) Application. Currently, Scorpio Labs is providing Full-Field Cell Morphology imaging and AI-powered analysis platforms to support laboratory professionals in the detection of cancers, anemia, infections, and other blood-related disease. This AI-based hematopathology platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis. Scopio's high resolution Full-Field imaging and AI-driven Decision Support System brings a much-desired digital transformation to hematopathology.